Document Detail


Life-threatening organ failure after lamotrigine therapy.
MedLine Citation:
PMID:  19380079     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We describe an 11-year-old girl with a seizure disorder who developed fever, rash, rhabdomyolysis, and multiorgan failure 2 weeks after commencing a transition from sodium valproate to lamotrigine therapy. To our knowledge, this patient represents the most severe life-threatening hypersensitivity lamotrigine reaction described in the pediatric literature. We recommend caution when prescribing lamotrigine to children on concomitant sodium valproate, and immediate discontinuation of lamotrigine and the provision of aggressive supportive care in patients with features of lamotrigine hypersensitivity.
Authors:
Lee P Ferguson; Paul I Dargan; Joanne L Hood; Shane M Tibby
Related Documents :
7572059 - Role of i-123-iomazenil spect imaging in drug resistant epilepsy with complex partial s...
16793949 - The spectrum of parathyroid gland dysfunction associated with the microdeletion 22q11.
10227649 - Vagus nerve stimulation for medication-resistant generalized epilepsy. e04 vns study gr...
12391359 - Asymmetric termination of secondarily generalized tonic-clonic seizures in temporal lob...
15944179 - The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures.
8292209 - Bilateral striatal lesions in childhood.
11793459 - Texture analysis of human liver.
12735609 - A new method for detection of postpneumonectomy broncho-pleural fistulas.
434689 - The use of thrombolytic agents: choice of patient, drug administration, laboratory moni...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric neurology     Volume:  40     ISSN:  1873-5150     ISO Abbreviation:  Pediatr. Neurol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-21     Completed Date:  2009-08-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508183     Medline TA:  Pediatr Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  392-4     Citation Subset:  IM    
Affiliation:
Department of Pediatric Intensive Care, Evelina Children's Hospital, Guy's and Saint Thomas' National Health Service Foundation Trust, London, United Kingdom. lee.ferguson@childrens.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticonvulsants / contraindications*
Child
Drug Therapy, Combination
Exanthema / chemically induced
Female
Fever / chemically induced
Humans
Multiple Organ Failure / chemically induced*,  therapy
Rhabdomyolysis / chemically induced
Seizures / drug therapy
Treatment Outcome
Triazines / contraindications*
Valproic Acid / therapeutic use
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Triazines; 84057-84-1/lamotrigine; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Benign familial neonatal convulsions: novel mutation in a newborn.
Next Document:  Hypomelanosis of Ito and Sturge-Weber syndrome without facial nevus: an association or a new syndrom...